New Composition of Tumor-Associated Peptides Binding to Human Leukocyte Antigen (HLA) Class I or II Molecules for Vaccine Use

• 收藏
• 分享

专利权人:

IMMATICS BIOTECHNOLOGIES GMBH

发明人:

LEWANDROWSKI, PETER,FLOHR, CHRISTIAN

申请号：

DK09005725

公开号：

DK2111867T3

申请日:

2009.04.23

申请国别(地区):

DK

年份:

2012

代理人:

摘要：

The present invention relates to novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules as vaccines for the use in immunotherapeutic methods. In particular, the present invention relates to formulations for the immunotherapy of cancer, in particular renal cancer. The present invention furthermore relates to vaccine compositions for eliciting anti-tumour immune responses.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/